Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANIK | BMY | AMGN | GILD | MRNA |
| Company | Anika Therapeutics | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 25.48 | 48.21 | 264.63 | 66.25 | 102.37 |
| High | 25.97 | 48.81 | 267.69 | 66.72 | 103.80 |
| Low | 25.46 | 48.12 | 260.68 | 66.16 | 100.73 |
| Last | 25.59 | 48.77 | 267.07 | 66.34 | 100.72 |
| Change | +0.16 | +0.47 | +4.32 | +0.18 | -1.28 |
| % Change | +0.63% | +0.97% | +1.64% | +0.27% | -1.25% |
| Volume | 18,576 | 4,600,104 | 1,177,958 | 3,667,571 | 1,224,654 |
| 20-Day Average Volume | 67,997 | 10,999,515 | 2,132,981 | 6,096,403 | 3,187,690 |
| Previous Close | 25.43 | 48.30 | 262.75 | 66.16 | 102.00 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 25.59 | 50.84 | 272.48 | 69.88 | 105.32 |
| 20-Day Raw Stochastic | 39.49% | 15.69% | 23.78% | 5.83% | 23.15% |
| 20-Day Relative Strength | 53.41% | 39.82% | 42.20% | 29.10% | 48.09% |
| Weighted Alpha | +5.03 | -29.37 | +6.78 | -24.95 | -20.47 |
| Today's Opinion | 96% Buy | 72% Sell | 56% Sell | 100% Sell | 72% Buy |
| Previous Opinion | 80% Buy | 72% Sell | 56% Sell | 100% Sell | 72% Buy |
| Last Month's Opinion | 96% Buy | 24% Sell | 8% Sell | 72% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.68% since 04/12/24 | +0.85% since 04/12/24 | +0.01% since 04/12/24 | -2.50% since 04/12/24 | -3.58% since 04/12/24 |
| Low | 24.97 on 04/15/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 99.90 on 04/18/24 |
| High | 25.97 on 04/19/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 106.42 on 04/16/24 |
| 1-Month | |||||
| %Chg | +1.18% since 03/19/24 | -6.00% since 03/19/24 | -1.63% since 03/19/24 | -9.60% since 03/19/24 | -3.56% since 03/19/24 |
| Low | 24.90 on 04/12/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 97.00 on 04/03/24 |
| High | 26.85 on 04/04/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 115.89 on 04/09/24 |
| 3-Month | |||||
| %Chg | +15.42% since 01/19/24 | -2.83% since 01/19/24 | -13.16% since 01/19/24 | -23.97% since 01/19/24 | +1.68% since 01/19/24 |
| Low | 21.00 on 03/14/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 84.06 on 02/13/24 |
| High | 27.31 on 03/06/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 115.89 on 04/09/24 |
| 6-Month | |||||
| %Chg | +35.11% since 10/19/23 | -13.79% since 10/19/23 | -4.74% since 10/19/23 | -15.39% since 10/19/23 | +23.07% since 10/19/23 |
| Low | 18.08 on 10/25/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 62.55 on 11/02/23 |
| High | 27.31 on 03/06/24 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 115.97 on 01/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 377,636 | 97,892,464 | 140,812,720 | 82,374,304 | 39,053,760 |
| Shares Outstanding, K | 14,850 | 2,026,759 | 535,919 | 1,245,077 | 382,880 |
| Annual Sales | 166,660,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | -82,670,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 42,970,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,811,000,000 |
| Last Quarter Net Income | -63,000,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 217,000,000 |
| 60-Month Beta | 0.76 | 0.39 | 0.58 | 0.19 | 1.62 |
| Per-Share Information | |||||
| Most Recent Earnings | -4.30 on 03/13/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 0.55 on 02/22/24 |
| Latest Earnings Date | 05/14/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.38 | 14.16 | 9.96 | 0.00 |